Aarti Pharmalabs Ltd Share Price & Stock Analysis

Aarti Pharmalabs Ltd (NSE: AARTIPHARM, BSE: 543748) is a Mumbai, Maharashtra-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹8,374 Cr, it ranks #650 by market cap among the 6,197 Indian listed companies on FinBizNet, and #4 of 26 in Pharmaceutical Contract Manufacturing Services. At ₹996.00 (as of 16 Nov 2026), the share price is 2.3% below its 52-week high of ₹1,019.50 and 70.3% above its 52-week low of ₹585.00. The share price is up 15.4% over one year and up 14.2% over three months.

Key Metrics

Current Price₹996.00
Market Cap₹8,374 Cr
NSE SymbolAARTIPHARM
BSE Code543748
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryPharmaceuticals > Pharmaceutical Contract Manufacturing Services
P/E Ratio52.5
Return on Equity8.49%
Return on Assets5.84%
52-Week Range₹585.00 – ₹1,019.50
1-Year Price Change+15.4%
3-Month Price Change+14.2%
Beta (1Y)0.43
Dividend Yield0.40%
HeadquartersMumbai, Maharashtra
Websitewww.aartipharmalabs.com

Latest Quarterly Results — Q2 FY27

Revenue₹610 Cr
Net Profit₹71 Cr
Net Margin11.7%
EPS (Basic)₹7.88
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Aarti Pharmalabs Ltd Quarterly Revenue and Profit Trend

Aarti Pharmalabs Ltd reported revenue of ₹610 Cr in Q2 FY27, up 45.9% from ₹418 Cr in Q2 FY26 and up 13.9% from ₹536 Cr in Q1 FY27. It posted a net profit of ₹71 Cr for the quarter, against a net profit of ₹28 Cr in Q2 FY26 (up 156.0%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹386 Cr (Q1 FY26) to ₹610 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹610 Cr₹71 Cr11.7%
Q1 FY27₹536 Cr₹76 Cr14.2%
Q4 FY26₹583 Cr₹61 Cr10.5%
Q3 FY26₹432 Cr₹48 Cr11.1%
Q2 FY26₹418 Cr₹28 Cr6.7%
Q1 FY26₹386 Cr₹50 Cr12.8%
Q4 FY25₹564 Cr₹88 Cr15.7%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 39.66% of Aarti Pharmalabs Ltd's shares as of Sept 2026, against 42.88% in Sept 2025 (−3.22 percentage points). Delivery averaged 42.9% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Aarti Pharmalabs Ltd

Aarti Pharmalabs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally. The company offers active pharmaceutical ingredients for various therapeutic areas, such as cardiovascular, anti-asthmatic, anti-cancer, anti-coagulant, anti-diabetic, arthritis, central nervous system agent, skincare, overactive bladder, calcimimetic, decongestant, anti-thalassaemic, analgesic, and ophthalmologic medications. It also provides contract development and manufacturing services for drug substance projects. In addition, the company offers intermediates; xanthine derivatives, including caffeine, theophylline anhydrous, aminophylline, etophylline, and theophylline; and acid and allied products, including sulphuric acid, sulphur trioxide, oil, dimethyl sulphate, diethyl sulphate, and sodium vinyl sulfonate. The company was formerly known as Aarti Organics Limited. Aarti Pharmalab

Products and Services

1. Pharmacuticals-This segment engages in the manufacturing and sale of pharmaceutical products. 2. NA-NA 3. NA-NA 4. NA-NA

Business Segments

1. Pharmeceuticals-100%

Aarti Pharmalabs Ltd vs Peers — Pharmaceutical Contract Manufacturing Services

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Torrent Pharma Ltd.₹1,79,494 Cr73.616.98%₹4,979 Cr+30.4%
Aether Industries Limited₹21,710 Cr101.89.81%₹347 Cr+127.8%
Alivus Life Sciences Ltd₹17,862 Cr31.518.36%₹682 Cr+64.0%
Aarti Pharmalabs Ltd₹8,374 Cr52.58.49%₹610 Cr+15.4%
Solara Active Pharma Sciences Limited₹3,225 Crn/m-0.63%₹417 Cr+22.1%
Sai Parenteral's Limited₹2,235 Cr115.82.88%₹195 Cr—
KRM Ayurveda Limited₹521 Cr25.917.54%₹32 Cr—
Trident Lifeline Limited₹511 Cr26——+37.6%
Infinium Pharmachem Limited₹436 Cr36.410.54%—+11.7%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Aarti Pharmalabs Ltd?

Aarti Pharmalabs Ltd is trading at ₹996.00, with a market capitalisation of ₹8,374 Cr.

Which sector does Aarti Pharmalabs Ltd belong to?

Aarti Pharmalabs Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).

What are the key financial ratios of Aarti Pharmalabs Ltd?

Aarti Pharmalabs Ltd has a P/E of 52.5 and a return on equity of 8.49%.

What is the stock symbol of Aarti Pharmalabs Ltd?

Aarti Pharmalabs Ltd is listed on the NSE under the symbol AARTIPHARM and on the BSE under the scrip code 543748.

How has Aarti Pharmalabs Ltd's share price moved over the past year?

Aarti Pharmalabs Ltd's share price is up 15.4% over one year and up 14.2% over three months. Its 52-week range is ₹585.00 to ₹1,019.50.

What were Aarti Pharmalabs Ltd's latest quarterly results?

In Q2 FY27, Aarti Pharmalabs Ltd reported revenue of ₹610 Cr and net profit of ₹71 Cr, with basic EPS of ₹7.88 (consolidated, parsed from the company's exchange filing).

How have Aarti Pharmalabs Ltd's revenue and profit changed over the past year?

Aarti Pharmalabs Ltd reported revenue of ₹610 Cr in Q2 FY27, up 45.9% from ₹418 Cr in Q2 FY26 and up 13.9% from ₹536 Cr in Q1 FY27.

What is the promoter holding in Aarti Pharmalabs Ltd?

Promoters held 39.66% of Aarti Pharmalabs Ltd's shares as of Sept 2026, against 42.88% in Sept 2025 (−3.22 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.